Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- ‘Surging Burden’ of Anal Cancer Requires More Investigation, Education
-
- 8 News Updates to Mark IBS Awareness Month
- Physicians Must Recognize CMV in Patients With HIV/AIDS Brian Mulhall, MD
- FDA Approves Sovaldi, Harvoni for Pediatric Patients with HCV
- FDA Approves Symproic for OIC in Adults With Chronic Noncancer Pain
- FDA Clears Device for Simplifying Enteral Nutrition Delivery
- The Rise of Anal Cancer Calls for GIs to Expand Awareness, Prevention Edward V. Loftus Jr., MD
- AGA Issues 10 Best Practice Recommendations for Long-term PPI Use
- Committee Presents Guideline for Eliminating HBV, HCV in the US by 2030
-
- Celiac Disease Triggered by Common Reovirus
- Gastric Acid Suppressants Increase Risk for Recurrent C. difficile
- Water Exchange Increases ADR During Screening Colonoscopy
- Expert: Three HCV Drugs may not be Better Than Two
- Hospital-acquired CDI Rates Persist Despite Enhanced Cleaning
- Imaging Modalities Provide Confirmative Results of NAFLD, NASH
- Nearly 80% Respond to Novel Growth Factor for NASH
- Treat C. difficile Based on Severity of Disease
-
- Should Planned Surgery be Considered for Large, Localized Anal Cancers?
- CDC Reports Case of HCV Transmission Following Reuse of Syringes
- FDA Warns IBS Drug Viberzi may Cause Severe Pancreatitis in Patients Without Gallbladder
- Finch, Takeda Partner to Develop Microbiome Therapies for IBD
- USC Researcher Awarded Grant to Study Link Between GERD, Esophageal Cancer